Navigating the Covid Confusion ~> 72 hours. From symptom onset. The antiviral treatment window for covid. There’s a study, overlooked by almost everyone, that shows this.

Navigating the Covid Confusion

Title: “Hydroxychloroquine / azithromycin in COVID-19: The association between time to treatment and case fatality rate”

Abstract: “A total of 1265 COVID-19 patients with an average age of 44.5 years were studied…41% with at least one comorbidity…No patient treated within the first 72 h of illness died.” [not a small study and included about 500 high risk patients]

Conclusion: “The case fatality rate in COVID-19 outpatients treated with hydroxychloroquine/azithromycin wasassociated with the number of days of illness on which treatment was started. ” Yes, hydroxychloroquine works. But the treatment window is narrow. HCQ has to be used on ambulatory patients with mild disease.

Let’s have a look at what the FDA said about using HCQ for covid when it retracted the EUA for hydroxychloroquine…

“Hospitalized patients were likely to have greater prospect of benefit (compared to ambulatory patients with mild illness)….”

So the FDA…

View original post 428 more words

About michael burgwin

A child of the peace and antiWar movements, a Truther with self-diagnosed Opposition Defiance Disorder, formerly politically liberal tho now politically marooned, and Post-Doomer, on any issue, I trend to the conspiracy side, sort through the absurd, fantastical and insane, until I find firm ground usually located just the other side of the censorship firewall of propaganda and orthodoxy, dogma, and other either / or thinking.

View all posts by michael burgwin →

This entry was posted in Uncategorized. Bookmark the permalink.